Lexicon to Present Analyses of INPEFA™ (sotagliflozin

THE WOODLANDS, Texas, Aug. 21, 2023 -- Lexicon Pharmaceuticals, Inc. today announced that analyses of clinical study results relating to INPEFA™ , its recently approved drug for heart...

Related Keywords

Michigan , United States , Texas , Netherlands , Ann Arbor , Amsterdam , Noord Holland , Americans , American , Carrie Siragusa , Marc Bonaca , Alina Cocuzza , Bertram Pitt , Lexicon Pharmaceuticals Inc , University Of Colorado Anschutz Medical Campus , American Heart Association , Nasdaq , Lexicon Pharmaceuticals , Exchange Commission , Amsterdam Convention Center , Drug Administration , Globenewswire Inc , University Of Michigan , School Of Medicine , Convention Center , Science Box , Colorado Anschutz Medical Campus , Concomitant Use , Insulin Secretagogues , Mycotic Infections , Glucose Test , Adverse Reactions , Specific Populations , Late Breaking Science Session , Heart Association , Scientific Sessions , New England Journal , Recent Worsening Heart Failure , Investor Inquiries , Media Inquiries , Markets ,